Tlando Improves Eczema Severity in Hypogonadal Men: 18-Month Multicenter Study
Reading Time: 2 minutesIntroduction Eczema, clinically termed atopic dermatitis (AD), affects approximately 13% of children and 7-10% of adults in the United States, with a notable prevalence among males over 40 exhibiting hypogonadism. Hypogonadism, characterized by diminished testosterone production, correlates with exacerbated inflammatory skin conditions due to impaired epidermal barrier function and dysregulated cytokine profiles. Tlando® (testosterone undecanoate) oral capsules represent a novel,... Read more »
